Connection

JAKUB TOLAR to Child, Preschool

This is a "connection" page, showing publications JAKUB TOLAR has written about Child, Preschool.
Connection Strength

0.348
  1. Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology. BMC Cancer. 2015 Oct 23; 15:769.
    View in: PubMed
    Score: 0.038
  2. Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2015 Apr; 135(4):1193-1197.
    View in: PubMed
    Score: 0.035
  3. Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation. 2011 Oct 20; 8:144.
    View in: PubMed
    Score: 0.029
  4. Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions. Cytotherapy. 2010 Dec; 12(8):971-81.
    View in: PubMed
    Score: 0.026
  5. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010 Aug 12; 363(7):629-39.
    View in: PubMed
    Score: 0.026
  6. Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation. Transplant Cell Ther. 2024 10; 30(10):1005.e1-1005.e17.
    View in: PubMed
    Score: 0.017
  7. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. JCI Insight. 2021 11 22; 6(22).
    View in: PubMed
    Score: 0.014
  8. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. J Hum Genet. 2020 Jan; 65(2):79-89.
    View in: PubMed
    Score: 0.013
  9. Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes. Sci Rep. 2019 Oct 01; 9(1):14105.
    View in: PubMed
    Score: 0.012
  10. Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation. Pediatr Res. 2020 01; 87(1):104-111.
    View in: PubMed
    Score: 0.012
  11. Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes. Genet Med. 2019 11; 21(11):2552-2560.
    View in: PubMed
    Score: 0.012
  12. Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2017 Oct; 23(10):1701-1713.
    View in: PubMed
    Score: 0.011
  13. Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation. J Pediatr. 2016 Jun; 173:242-4.
    View in: PubMed
    Score: 0.010
  14. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. Mol Genet Metab. 2016 Mar; 117(3):373-7.
    View in: PubMed
    Score: 0.010
  15. Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure. Am J Hematol. 2015 Oct; 90(10):892-6.
    View in: PubMed
    Score: 0.009
  16. Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2015 Sep; 135(9):2319-2321.
    View in: PubMed
    Score: 0.009
  17. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015 Mar 26; 125(13):2164-72.
    View in: PubMed
    Score: 0.009
  18. An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant. 2015 Jan; 21(1):81-8.
    View in: PubMed
    Score: 0.009
  19. Incidence of intracranial germ cell tumors by race in the United States, 1992-2010. J Neurooncol. 2014 Nov; 120(2):381-8.
    View in: PubMed
    Score: 0.009
  20. Pericardial effusion after pediatric hematopoietic cell transplant. Pediatr Transplant. 2013 May; 17(3):294-9.
    View in: PubMed
    Score: 0.008
  21. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011 Aug 18; 118(7):1971-8.
    View in: PubMed
    Score: 0.007
  22. Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes. Eur J Pediatr. 2011 Aug; 170(8):1049-54.
    View in: PubMed
    Score: 0.007
  23. Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation. J Clin Pharmacol. 2011 May; 51(5):679-86.
    View in: PubMed
    Score: 0.006
  24. Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT). J Clin Pharmacol. 2008 Apr; 48(4):485-94.
    View in: PubMed
    Score: 0.006
  25. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood. 2006 Oct 15; 108(8):2874-80.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.